Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization

The Syneos Health Insights Hub, a dynamic destination for what's next thinking and future-focused insights, today released 2020 Health Trends: Changing Lives and Life Sciences. This annual trends report...

SYNH : 57.36 (+2.23%)
Working and Rallying

Working and Rallying

GTES : 13.14 (+3.87%)
SLP : 33.10 (+2.67%)
PTF : 74.66 (+0.37%)
CUB : 65.09 (+0.22%)
DOMO : 23.65 (-0.30%)
SYNH : 57.36 (+2.23%)
CMTL : 34.85 (+0.69%)
XPER : 19.89 (+2.10%)
MSI : 161.97 (+0.12%)
SYNH vs. HMSY: Which Stock Should Value Investors Buy Now?

SYNH vs. HMSY: Which Stock Is the Better Value Option?

SYNH : 57.36 (+2.23%)
HMSY : 29.29 (-0.64%)
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released "Real World Value: Advancing Payer Understanding of RWE in Rare Disease," a report identifying...

SYNH : 57.36 (+2.23%)
Is Syneos Health (SYNH) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

SYNH : 57.36 (+2.23%)
Syneos Health Collaborates with AiCure for Patient Engagement

Syneos Health (SYNH) aims to optimize patient engagement and trial success by partnering with AiCure.

HAE : 117.17 (-0.32%)
NUVA : 73.85 (+0.09%)
GWPH : 105.70 (+2.74%)
SYNH : 57.36 (+2.23%)
Syneos Health to Present at the Jefferies 2019 London Healthcare Conference

Syneos Health(R) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 57.36 (+2.23%)
Bernadette Connaughton Appointed to Syneos Health Board of Directors

Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and a Contract Commercial Organization (CCO), today announced the appointment...

ZEAL : 31.16 (+0.52%)
HALO : 18.72 (-0.11%)
SYNH : 57.36 (+2.23%)
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to...

SYNH : 57.36 (+2.23%)
SYNH vs. OMCL: Which Stock Should Value Investors Buy Now?

SYNH vs. OMCL: Which Stock Is the Better Value Option?

SYNH : 57.36 (+2.23%)
OMCL : 80.92 (-0.91%)
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View

Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.

TMO : 319.36 (+0.40%)
NUVA : 73.85 (+0.09%)
RMD : 152.25 (+1.18%)
SYNH : 57.36 (+2.23%)
Syneos Health (SYNH) Surpasses Q3 Earnings Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 4.82% and -0.44%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 57.36 (+2.23%)
Syneos Health Reports Third Quarter 2019 Results

Highlights

SYNH : 57.36 (+2.23%)
Syneos Health, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Syneos Health, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 31, 2019 at 8:00 AM Eastern...

SYNH : 57.36 (+2.23%)
ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand

ResMed (RMD) registers growth at CER across its key operating segments in Q1.

SYK : 199.77 (+0.90%)
RMD : 152.25 (+1.18%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)
Integra LifeSciences' (IART) Earnings Top Estimates in Q3

We are upbeat about the year-over-year revenue growth in Integra LifeSciences' (IART) Codman Specialty Surgical segment.

SYK : 199.77 (+0.90%)
IART : 61.96 (+1.14%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)
Edwards Lifesciences (EW) Beats on Q3 Earnings, Ups EPS View

Edwards Lifesciences (EW) reports strong Q3 sales on the recent FDA indication expansion of SAPIEN 3 and SAPIEN 3 Ultra systems.

EW : 230.70 (+0.16%)
RMD : 152.25 (+1.18%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)
Varian (VAR) Earnings and Revenues Surpass Estimates in Q4

Varian (VAR) gains from core Oncology segment's solid contribution in fiscal Q4.

VAR : 141.86 (+1.90%)
RMD : 152.25 (+1.18%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)
Align Technology (ALGN) Beats on Q3 Earnings, Margins Fall

We are upbeat about Align Technology (ALGN) witnessing continued momentum in Invisalign volumes across all geographies

SYK : 199.77 (+0.90%)
ALGN : 268.39 (-2.49%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)
Boston Scientific (BSX) Beats on Q3 Earnings, Tapers EPS View

Boston Scientific (BSX) is making an all-out effort to solidify its core businesses and invest in the new technologies as well as the global markets. This reflects on the sales uptick in Q3.

VAR : 141.86 (+1.90%)
BSX : 44.67 (+1.94%)
MCK : 143.93 (+0.40%)
SYNH : 57.36 (+2.23%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -2.61 , AIZ +0.17 , SBAC -7.72 , SO +0.02 , WELL -2.04
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar